Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE

Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension). FDA determined that the filing is a Class 2 resubmission and therefore assigned a Prescription Drug User Fee Act (PDUFA) action date of October 30, 2021. XIPERE is an investigational therapy with a proposed indication of treatment of macular edema associated with uveitis.

According to the company, Bausch + Lomb has the exclusive license for the commercialization and development of XIPERE in the United States and Canada.

“If approved by the FDA, XIPERE would be the first therapy available utilizing the suprachoroidal space for patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis,” said Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb.

“XIPERE has the potential to advance the care of people suffering from macular edema with uveitis,” said George Lasezkay, Pharm.D., J.D., president and CEO, Clearside. “If approved, XIPERE would be our first commercial product and the first approved drug to be delivered into the suprachoroidal space (SCS®).”

XIPERE is designed for suprachoroidal administration via Clearside’s patented, proprietary SCS Microinjector® that offers unprecedented access to the back of the eye where sight-threatening disease often occurs.

Click HERE for the full press release.

Featured Posts

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read More

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read More

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read More

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read More

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more

The Optical Foundry Innovates Industry-Leading Augmented Reality Shopping Experience

The Optical Foundry, holding company of prominent indie eyewear brand OGI Eyewear, announces the launch of its Optical Foundry Mobile App, that allows for a best-in-class Virtual Try-On (VTO) experience.

Learn More

Marcolin: Lara Marogna New Group Style & Product Development Director

Marcolin announces the appointment of Lara Marogna as Group Style & Product Development Director, with immediate effect.

Read more

Strak Eyewear by Teka Sweeps VEE with Favorite Product Award and People’s Choice Award

Strak Amsterdam has won two prestigious awards at Vision Expo East.

Read more

Nautica Intros New Tenite™ Renew Collection

Conquer the sun in style with Nautica Eyewear’s trendy round sunglasses from their Tenite Renew collection.

Read more

Repeated Stress Can Speed Up Aging in the Eye and Glaucoma

A new research study published in the journal Aging Cell, shows that stress including higher eye pressure from Glaucoma can cause changes in retinal cells similar to what is seen in natural aging.

Read more